Haemophilia
Also known as: Hemophilia, Haemophilia A, Haemophilia B, Factor VIII deficiency, Factor IX deficiency
Haemophilia is an inherited or acquired coagulopathy characterised by deficient activity of clotting factor VIII or IX. Clinical management prioritises the prevention and resolution of intra-articular, intramuscular, and internal haemorrhage via specialist haemostatic replacement therapy and prophylaxis coordinated by a haemophilia treatment centre. Within a TCM framework, traditional diagnostic categories may be utilised to address secondary symptoms such as fatigue and sleep disturbances; however, TCM cannot rectify factor deficiencies or substitute for standard haematological care. Existing literature, including the rare-disease correspondence and unrelated studies cited here, fails to establish the efficacy or safety of acupuncture or herbal medicine in the management of haemophilia. The patterns described serve as traditional references only and do not constitute treatment recommendations. Invasive procedures and herbal prescriptions necessitate explicit haematological consultation and extreme caution.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to the prophylaxis and emergency protocols established by the haemophilia treatment centre, and maintain medical identification and treatment documentation at all times.
- •Prioritise low-impact exercise and musculoskeletal strengthening under the guidance of a physiotherapist experienced in haemophilia; cease activity and seek clinical advice upon the onset of new pain or swelling.
- •Maintain regular nutritional intake and consistent sleep hygiene, and refer persistent fatigue to a medical practitioner for investigation rather than employing self-prescribed supplementation.
- •Coordinate all dental interventions and surgical procedures through the haemophilia treatment centre, and clear all over-the-counter medications or supplements with the specialist team before use.
Cautions & Contraindications
- •Do not offer needling during suspected active bleeding, over haematomas or recently bleeding joints, or without an individual haemostatic plan agreed with the treating specialist. The supplied rare-disease review does not establish procedural safety in haemophilia; this is a precaution, not a trial-derived conclusion.[]
- •Do not transfer electroacupuncture or surround-needling protocols from the ankle-sprain trial to haemophilic joint pain. That abstract does not establish safety or benefit in haemophilia, and an apparent sprain may represent a bleed.[]
- •Avoid bloodletting, wet cupping, vigorous scraping and deep traumatic massage because of bleeding risk. Do not start herbal formulas or alter haemostatic medicines without specialist review; publication volume is not evidence of safety. Source [1] supports the evidence limitation, not these specific procedural rules.[]
- •Pregnancy, childhood, inhibitors, acquired haemophilia, liver disease or additional antithrombotic treatment require heightened specialist oversight. The supplied literature does not establish safe acupuncture or herbal protocols for these groups.[]
When to reassess or seek care again
If the haemophilia team approves a supportive care plan, review within 1–2 weeks using a symptom-specific measure such as fatigue and pain scores from 0–10, nights of disturbed sleep, walking tolerance and recorded bleeding or bruising episodes. Record adverse events after every contact. Stop the adjunct and seek immediate specialist advice for new bleeding, expanding bruising or functional deterioration. If there is no meaningful improvement within 2–4 weeks, discontinue or revise the adjunct and reassess medical causes; never change prophylaxis according to a TCM pattern.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Intractable & rare diseases research · 2026
- Journal of pain research · 2026
- Frontiers in medicine · 2025
- Frontiers in neurology · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
